Study of consolidation chemotherapy after definitive chemoradiation in locally advanced carcinoma esophagus in a tertiary care hospital

Wajahat Ahmad, A. Najmi, N. Wani, S. Wani, S. Banday, Shahida Nasreen
{"title":"Study of consolidation chemotherapy after definitive chemoradiation in locally advanced carcinoma esophagus in a tertiary care hospital","authors":"Wajahat Ahmad, A. Najmi, N. Wani, S. Wani, S. Banday, Shahida Nasreen","doi":"10.15587/2519-4798.2023.274476","DOIUrl":null,"url":null,"abstract":"Concurrent chemoradiation (CCRT) is considered the standard of care in locally advanced and inoperable carcinoma oesophagus patients. However, the majority of these patients have residual disease after completion of CCRT, and there are no definitive treatment guidelines for the management of the residual disease. Reports on consolidation chemotherapy for patients with oesophagal cancer after definitive CCRT are rare and have shown mixed results.\nThe aim of this study was to see the effects of consolidation chemotherapy in patients of CCRT who had residual disease and were not surgical candidates and also monitor its side effects.\nMaterial and methods: It was a prospective interventional protocol over 2 years where patients received 4 cycles of consolidation chemotherapy post-CCRT. These patients were followed after completion of chemotherapy for response, toxicity and survival.\nResults: 45 patients were initially enrolled for the study, histopathologically proven carcinoma of the oesophagus, out of which 30 patients finally received the full course of treatment and were available for final assessment. After consolidation chemotherapy, 23 (76.7 %) patients had a complete response, 3 (10 %) had a partial response, and 4 (13.3 %) had stable disease. There was no progression of the disease during treatment. The overall treatment protocol was well tolerated by all the patients. There were no grade IV toxicities. On follow-up till the compilation of this data, 23 (76.6 %) of the patients were alive, and 7 (23.3 %) died (disease-related events). Out of these 7 patients, 4 patients had a local failure, and 3 patients developed distant metastasis in the form of brain and liver metastasis.\nConclusion: Consolidation chemotherapy after concurrent chemoradiation in locally advanced, inoperable carcinoma oesophagus is a well-tolerable protocol with high chances of complete response rates","PeriodicalId":21672,"journal":{"name":"ScienceRise: Medical Science","volume":"100 8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ScienceRise: Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15587/2519-4798.2023.274476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Concurrent chemoradiation (CCRT) is considered the standard of care in locally advanced and inoperable carcinoma oesophagus patients. However, the majority of these patients have residual disease after completion of CCRT, and there are no definitive treatment guidelines for the management of the residual disease. Reports on consolidation chemotherapy for patients with oesophagal cancer after definitive CCRT are rare and have shown mixed results. The aim of this study was to see the effects of consolidation chemotherapy in patients of CCRT who had residual disease and were not surgical candidates and also monitor its side effects. Material and methods: It was a prospective interventional protocol over 2 years where patients received 4 cycles of consolidation chemotherapy post-CCRT. These patients were followed after completion of chemotherapy for response, toxicity and survival. Results: 45 patients were initially enrolled for the study, histopathologically proven carcinoma of the oesophagus, out of which 30 patients finally received the full course of treatment and were available for final assessment. After consolidation chemotherapy, 23 (76.7 %) patients had a complete response, 3 (10 %) had a partial response, and 4 (13.3 %) had stable disease. There was no progression of the disease during treatment. The overall treatment protocol was well tolerated by all the patients. There were no grade IV toxicities. On follow-up till the compilation of this data, 23 (76.6 %) of the patients were alive, and 7 (23.3 %) died (disease-related events). Out of these 7 patients, 4 patients had a local failure, and 3 patients developed distant metastasis in the form of brain and liver metastasis. Conclusion: Consolidation chemotherapy after concurrent chemoradiation in locally advanced, inoperable carcinoma oesophagus is a well-tolerable protocol with high chances of complete response rates
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
某三级医院局部晚期食管癌放化疗后巩固化疗的研究
同步放化疗(CCRT)被认为是局部晚期和不能手术的食管癌患者的标准治疗方法。然而,这些患者中的大多数在完成CCRT后仍有残留疾病,并且对于残留疾病的管理尚无明确的治疗指南。关于食管癌患者在确诊CCRT后的巩固化疗的报道很少,并且显示了不同的结果。本研究的目的是观察巩固化疗对有残留疾病且不适合手术的CCRT患者的影响,并监测其副作用。材料和方法:这是一项前瞻性介入方案,患者在ccrt后接受4个周期的巩固化疗,为期2年。这些患者在化疗完成后进行了反应,毒性和生存的随访。结果:45例患者最初被纳入研究,经组织病理学证实为食管癌,其中30例患者最终接受了全程治疗并可进行最终评估。巩固化疗后,23例(76.7%)患者完全缓解,3例(10%)患者部分缓解,4例(13.3%)患者病情稳定。治疗期间无病情进展。所有患者对整体治疗方案耐受良好。没有IV级毒性。随访至数据汇编时,23例(76.6%)患者存活,7例(23.3%)患者死亡(疾病相关事件)。在这7例患者中,4例发生局部衰竭,3例以脑和肝转移的形式发生远处转移。结论:局部晚期不能手术的食管癌在同步放化疗后进行巩固化疗是一种耐受性良好的方案,完全缓解率的机会很高
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
47
审稿时长
6 weeks
期刊最新文献
Analysis of exhaled breath condensate in patients with asthma and recurrent wheezing Sacrococcygeal pilonidal cyst with the disease onset as an anterior perianal abscess: a clinical case Body mass index, lipid profile, and endothelial dysfunction gene polymorphism in women with early-onset and late-onset preeclampsia Assessment of the implantation window and embryonic factor impact to the treatment of recurrent implantation failure (RIF). A prospective study Improvement of the methods of stopping nose bleeds in patients under antithrombotic therapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1